Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Japan flag Japan · Delayed Price · Currency is JPY
2,377.00
-2.00 (-0.08%)
Apr 24, 2025, 3:30 PM JST
-20.32%
Market Cap 537.57B
Revenue (ttm) 295.57B
Net Income (ttm) 29.59B
Shares Out 225.96M
EPS (ttm) 129.30
PE Ratio 18.40
Forward PE 16.28
Dividend 40.00 (1.67%)
Ex-Dividend Date Mar 28, 2025
Volume 720,700
Average Volume 1,284,185
Open 2,390.00
Previous Close 2,379.00
Day's Range 2,356.00 - 2,414.50
52-Week Range 2,013.00 - 3,688.00
Beta -0.35
RSI 57.04
Earnings Date May 13, 2025

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatologi... [Read more]

Founded 1899
Employees 7,259
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4527
Full Company Profile

Financial Performance

In 2023, Rohto Pharmaceutical's revenue was 270.84 billion, an increase of 13.48% compared to the previous year's 238.66 billion. Earnings were 30.94 billion, an increase of 17.28%.

Financial Statements

News

There is no news available yet.